The study authors say flu or RSV may increase the risk of S pneumoniae infection by damaging the bronchi and lung epithelium, ...

Panelists discuss how idiopathic pulmonary fibrosis (IPF), a progressive and often fatal interstitial lung disease, presents ...

The company's "next-generation" COVID-19 vaccine, mNexspike, was approved for adults 65 and older and younger people at risk ...

New research suggests that early impairment in mucosal IgA immunity may contribute to the later development of bronchiolitis ...

A new international study led by Helmholtz Munich and the University of Rostock reveals that emissions from modern gasoline ...

lung epithelium, lung immunity and lung regeneration. Alongside her role at AstraZeneca, Maria is also professor of respiratory pharmacology and head of the Respiratory Pharmacology Group at ...

Red blood cells and epithelial cells should be enumerated but are not included in the total white cell count. Differential cell counts are most frequently determined on slides prepared either by ...

Trial is evaluating the safety, tolerability, and efficacy of LTI-03 in idiopathic pulmonary fibrosis (IPF) with topline interim data expected in the first half of ...

Some 10 million people in the U.S. have oral premalignant disease: a group of diseases that show up as red patches, white ...

Creative Biolabs recently updated its antibody chip platform, expanding product arrays for phosphorylation signaling and ...

Immunic, Inc. ("Immunic" or the "Company") , a biotechnology company developing a clinical pipeline of orally administered, small molecule therapies for chronic inflammatory and autoimmune diseases, ...

Please note: If you switch to a different device, you may be asked to login again with only your ACS ID. Please note: If you switch to a different device, you may be asked to login again with only ...